Literature DB >> 21606257

Diffusion-attenuated MRI signal of renal allografts: comparison of two different statistical models.

Dirk Blondin1, Rotem Shlomo Lanzman, Janina Klasen, Axel Scherer, Falk Miese, Patric Kröpil, Hans-Jörg Wittsack.   

Abstract

OBJECTIVE: Contrast-enhanced MRI is considered problematic in renal allograft recipients because of the development of nephrogenic systemic fibrosis. Therefore, we assessed the clinical value of a monoexponential model and a distribution function model of diffusion-weighted imaging (DWI) in renal allografts.
MATERIALS AND METHODS: A total of 23 patients were divided into three groups, as follows: group A, stable renal allograft function for at least 6 months; group B, transplantation within the past 30 days, with good renal allograft function; and group C, an acute deterioration or decrease in renal allograft function. T2-weighted axial, T1-weighted coronal, and a paracoronal DWI sequences with 16 b values (b = 0-750 s/mm(2)) were performed on a 1.5-T scanner. Region of interest-based analysis of the apparent diffusion coefficient (ADC) of the renal cortex was used.
RESULTS: Monoexponential analysis showed mean (± SD) ADC values of 1932 ± 98, 2095 ± 246, and 1636 ± 200 10-(6) mm(2)/s for patient groups A, B, and C, respectively. The distribution function revealed a mean ADC of 2487 ± 185, 2850 ± 325, and 2142 ± 31410-(6) mm(2)/s for groups A, B, and C, respectively. The difference between groups A and B combined and group C (p < 0.005) was statistically significant for both models. R(2) yielded the best regression of mathematic fitting for the distribution function model (p < 0.0001). DISCUSSION: Unenhanced evaluation of renal allografts with DWI correlated well with renal function for both the monoexponential analysis and the distribution function model. There was no statistically significant difference in ADC values and renal allograft function between both types of analysis, but the distribution function showed the best regression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606257     DOI: 10.2214/AJR.10.5775

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  [Functional magnetic resonance imaging of the kidneys].

Authors:  R S Lanzman; M Notohamiprodjo; H J Wittsack
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

2.  Diffusion-weighted imaging in the assessment of renal function in patients with diabetes mellitus type 2.

Authors:  Tijana Mrđanin; Olivera Nikolić; Una Molnar; Milena Mitrović; Viktor Till
Journal:  MAGMA       Date:  2020-07-30       Impact factor: 2.310

3.  REnal Flow and Microstructure AnisotroPy (REFMAP) MRI in Normal and Peritumoral Renal Tissue.

Authors:  Andrea L Liu; Artem Mikheev; Henry Rusinek; William C Huang; James S Wysock; James S Babb; Thorsten Feiweier; David Stoffel; Hersh Chandarana; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2018-01-13       Impact factor: 4.813

4.  Value of diffusion-weighted MR imaging for the detection of nephritis.

Authors:  Benjamin Henninger; Miriam Reichert; Stefan Haneder; Stefan O Schoenberg; Henrik J Michaely
Journal:  ScientificWorldJournal       Date:  2013-11-11

Review 5.  Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation.

Authors:  Mick J M van Eijs; Arjan D van Zuilen; Anneloes de Boer; Martijn Froeling; Tri Q Nguyen; Jaap A Joles; Tim Leiner; Marianne C Verhaar
Journal:  Front Physiol       Date:  2017-05-16       Impact factor: 4.566

6.  Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: a systematic review and statement paper.

Authors:  Anna Caroli; Moritz Schneider; Iris Friedli; Alexandra Ljimani; Sophie De Seigneux; Peter Boor; Latha Gullapudi; Isma Kazmi; Iosif A Mendichovszky; Mike Notohamiprodjo; Nicholas M Selby; Harriet C Thoeny; Nicolas Grenier; Jean-Paul Vallée
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.